| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0037 | 0.9 |